Previous 10 | Next 10 |
Summary Expectations surrounding central bank policy, China’s gradual reopening and a lower US dollar are key to investor sentiment in the final stretch of 2022. Central banks have increased interest rates at the fastest rate on record, and there are signs that higher yields are ...
Summary Surging stocks show markets believe hopes of a soft landing by the Fed to be true. We disagree and stay underweight developed market (DM) stocks. U.S. stocks jumped and bond yields plunged after October CPI rose less than the market expected. But sticky core inflation keep...
Summary U.S. midterm elections: Win, lose or draw for markets? What sectors may benefit from a divided government. Will equity markets get the post midterm election bump? For further details see: U.S. Midterm Elections: Win, Lose Or Draw For Markets? ...
Summary Why the declines in tech on the S&P 500 may be hiding strength in other sectors from investors. The energy sector may still provide opportunities for investors. Insurers are not suffering the same challenges as other financials in the current high-rate environment....
Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...
Summary While a divided US government may look appealing, there are long-term risks amid resulting gridlock. The longest night belonged to the pollsters and pundits, whose predictions for a “red wave” did not come to fruition. Looking at historical relationships ...
Summary In the healthcare provider space, nursing expense is the largest component of salaries, wages, and benefits. Barring another disruptive COVID surge, however, we believe the market for nurses is now coming back into balance. If the reduction in contract labor expense co...
Summary Attached to the new US Inflation Reduction Act is a multipronged mandate on pharmaceutical companies to limit or lower drug prices. DNA sequencing has especially turbocharged pharmaceutical research, and the cost to use it has steadily fallen. The new law doesn’...
Summary The Health Care sector continues to generate alpha in 2022, but not all of its holdings are a source of relative safety. Edwards Lifesciences reported a poor Q3 and slashed guidance. Traders reacted harshly to the EPS miss. The stock still looks on the pricey side but ...
Summary The Health Care sector's 2022 return is half as poor as the S&P 500's this year, but the medical device industry features massive losses. One of the best-performing stocks in the industry YTD has an earnings report Wednesday morning. Boston Scientific features a fa...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Medical Devices Company Name:
IHI Stock Symbol:
NYSE Market:
2024-07-12 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-21 21:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...